Altered levels of acute phase proteins in the plasma of patients with schizophrenia

Analytical Chemistry

Volumn 78, Issue 11, 2006, Pages 3571-3576

  Yang, Yifeng ^a,b   Wan, Chunling ^a,b   Li, Huafang ^c   Zhu, Hui ^a,b   La, Yujuan ^a,b   Xi, Zhengrui ^a,b   Chen, Yongshuo ^a,b   Jiang, Lei ^a,b   Feng, Guoyin ^c   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENT FACTOR; HAPTOGLOBIN; PSYCHIATRIC SYNDROME; SCHIZOPHRENIA;

BRAIN; ELECTROPHORESIS; GENES; MASS SPECTROMETRY; PATIENT TREATMENT;

PROTEINS;

ACUTE PHASE PROTEIN; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 1 MICROGLOBULIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CERULOPLASMIN; CLUSTERIN; FICOLIN; FICOLIN 3; HAPTOGLOBIN; PREALBUMIN; PROTEOME; RETINOL BINDING PROTEIN; SERUM AMYLOID P; TRANSFERRIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; MALE; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHIZOPHRENIA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACUTE-PHASE PROTEINS; ADULT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 33744901161     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac051916x     Document Type: Article

References (31)

1. Harrison, P. J.; Owen, M. J. Lancet 2003, 361, 417-419.
2. Weinberger, D. R.; McClure, R. K. Arch. Gen. Psychiatry 2002, 59, 553-558.
3. Hanson, D. R.; Gottesman, I. I. BMC Med. Genet. 2005, 6, 7.
4. Lin, A; Kenis, G.; Bignotti, S.; Tura, G. J.; De Jong, R.; Bosmans, E.; Pioli, R.; Altamura, C.; Scharpe, S.; Maes, M. Schizophr. Res. 1998, 32, 9-15.
5. Czlonkowska, A.; Ciesielska, A.; Gromadzka, G.; Kurkowska-Jastrzebska, I. Curr. Pharm. Des. 2005, 11, 1017-1030.
6. Akiyama, K. Schizophr. Res. 1999, 37, 97-106.
7. Boin, F.; Zanardini, R.; Pioli, R.; Altamura, C. A.; Maes, M.; Gennarelli, M. Mol. Psychiatry 2001, 6, 79-82.
8. Erbagci, A. B.; Herken, H.; Koyluoglu, O.; Yilmaz, N.; Tarakcioglu, M. Mediators Inflammation 2001, 10, 109-115.
9. Gilmore, J. H.; Jarskog, L. F.; Vadlamudi, S.; Lauder, J. M. Neuropsychopharmacology 2004, 29, 1221-1229.
10. Van Oostrum, J.; Voshol, H. Am. J. Psychiatry 2002, 159, 208.
11. Spitzer, R. L.; Williams, J. B.; Gibbon, M.; First, M. B. Arch. Gen. Psychiatry 1992, 49, 624-629.
12. Wong, C. T.; Tsoi, W. F.; Saha, N. Schizophr. Res. 1996, 22, 165-171.
13. Maes, M.; Delange, J.; Ranjan, R.; Meltzer, H. Y.; Desnyder, R.; Cooremans, W.; Scharpe, S. Psychiatry Res. 1997, 66, 1-11.
14. Moshage, H. J. Pathol. 1997, 181 Suppl, 257-266.
15. Rudduck, C.; Franzen, G.; Frohlander, N.; Lindstrom, L. Hum. Hered. 1985, 35, 65-68.
16. Maes, M.; Delanghe, J.; Bocchio Chiavetto, L.; Bignotti, S.; Tura, G. B.; Pioli, R.; Zanardini, R.; Altamura, C. A. Psychiatry Res. 2001, 104, 1-9.
17. Lewis, C. M.; Levinson, D. F.; Wise, L. H.; DeLisi, L. E.; Straub, R. E.; Hovatta, I.; Williams, N. M.; Schwab, S. G.; Pulver, A. E.; Faraone, S. V.; Brzustowicz, L M.; Kaufmann, C. A.; Garver, D. L.; Gurling, H. M.; Lindholm, E.; Coon, H.; Moises, H. W.; Byerley, W.; Shaw, S. H.; Mesen, A.; Sherrington, R.; O'Neill, F. A.; Walsh, D.; Kendler, K. S.; Ekelund, J.; Paunio, T.; Lonnqvist, J.; Peltonen, L.; O'Donovan, M. C.; Owen, M. J.; Wildenauer, D. B.; Maier, W.; Nestadt, G.; Blouin, J. L.; Antonarakis, S. E.; Mowry, B. J.; Silverman, J. M.; Crowe, R. R.; Cloninger, C. R.; Tsuang, M. T.; Malaspina, D.; Harkavy-Friedman, J. M.; Svrakic, D. M.; Bassett, A. S.; Holcomb, J.; Kalsi, G.; McQuillin, A.; Brynjolfson, J.; Sigmundsson, T.; Petursson, H.; Jazin, E.; Zoega, T.; Helgason, T. Am. J. Hum. Genet. 2003, 73, 34-48.
18. Goodman, A. B. Am. J. Med. Genet. 1994, 54, 271-278.
19. Paunio, T.; Tuulio-Henriksson, A.; Hiekkalinna, T.; Perola, M.; Varilo, T.; Partonen, T.; Cannon, T. D.; Lonnqvist, J.; Peltonen, L. Hum. Mol. Genet. 2004, 13, 1693-1702.
20. Herbon, N.; Werner, M.; Braig, C.; Gohlke, H.; Dutsch, G.; Illig, T.; Altmuller, J.; Hampe, J.; Lantermann, A.; Schreiber, S.; Bonifacio, E.; Ziegler, A.; Schwab, S.; Wildenauer, D.; van den Boom, D.; Braun, A.; Knapp, M.; Reitmeir, P.; Wjst, M. Genomics 2003, 81, 510-518.
21. Matthysse, S.; Holzman, P. S.; Gusella, J. F.; Levy, D. L.; Harte, C. B.; Jorgensen, A.; Moller, L.; Parnas, J. Am. J. Med. Genet. B Neuropsychiatry Genet. 2004, 128, 30-36.
22. Doherty, N. S.; Littman, B. H.; Reilly, K.; Swindell, A. C.; Buss, J. M.; Anderson, N. L. Electrophoresis 1998, 19, 355-363.
23. Goodman, A. B. Am. J. Med. Genet. 1998, 81, 347-348.
24. Park, N.; Juo, S. H.; Cheng, R; Liu, J.; Loth, J. E.; Lilliston, B.; Nee, J.; Grunn, A; Kanyas, K.; Lerer, B.; Endicott, J.; Gilliam, T. C.; Baron, M. Mol. Psychiatry 2004, 9, 1091-1099.
25. Kampman, O.; Anttila, S.; Illi, A.; Mattila, K. M.; Rontu, R.; Leinonen, E.; Lehtimaki, T. J. Hum. Genet. 2004, 49, 355-359.
26. Liu, W.; Breen, G.; Zhang, J.; Li, S.; Gu, N.; Feng, G.; Bai, S.; Shen, T.; Yu, A.; Xue, H.; St. Clair, D.; He, L. Schizophr. Res. 2003, 62, 225-230.
27. Dean, B.; Laws, S. M.; Hone, E.; Taddei, K; Scarr, E.; Thomas, E. A.; Harper, C.; McClean, C.; Masters, C.; Lautenschlager, N.; Gandy, S. E.; Martins, R. N. Biol. Psychiatry 2003, 54, 616-622.
28. Mahadik, S. P.; Khan, M. M.; Evans, D. R.; Parikh, V. V. Schizophr. Res. 2002, 58, 55-62.
29. Thomas, E. A.; Dean, B.; Pavey, G.; Sutcliffe, J. G. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 4066-4071.
30. Jiang, L.; Lindpaintner, K.; Li, H. F.; Gu, N. F.; Langen, H.; He, L.; Fountoulakis, M. Amino Acids 2003, 25, 49-57.
31. Sousa, M. M.; Berglund, L.; Saraiva, M. J. J. Lipid Res. 2000, 41, 58-65.